Health Condition 1: O14- Pre-eclampsia
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Intervention4: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women having gestational age between 11 to 16 weeks from LMP and/or CRL
Exclusion criteria
Exclusion criteria: Unconscious or severely ill status Having major fetal abnormality identified at the time of enrollment Known bleeding disorder such as von Willebrand?s disease Participation in another drug trial within 28 days before screening Pregnant women diagnosed with Preeclampsia Pregnant women who are already on aspirin medication Pregnant women with a known case of diabetes or chronic HTN Twins or multiple pregnancies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the Diagnostic Accuracy of the Preeclampsia screening testTimepoint: At 6 time points of testing during the study (gestational age) 1. 11 to 12 weeks ? 6 days 2. 13 to 15 weeks ? 6 days 3. 16 to 19 weeks ? 6 days 4. 20 to 28 weeks ? 6 days 5. 28 to 34 weeks ? 6 days 6. after 35 weeks ? 0 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Using patient history and other clinical findings (MAP, USG findings, maternal factors) and combinations for enhanced diagnostic accuracyTimepoint: 6 time points;Association of risk factors with PreeclampsiaTimepoint: 6 time points | — |
Countries
India
Contacts
Public ContactDr Neha Lasure
Intignus Biotech Pvt Ltd
Outcome results
None listed